← HDFC Mutual Fund

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

Equity Data as of May 2026 Comparing Apr 2026 → May 2026
Share: WhatsApp X
Stocks Held
32
May 2026
Equity Holdings
₹2,331.67 Cr
Equity only, excl. debt & cash
Top 5 Weight
33.1%
Moderate
Top 10 Weight
54.5%
Moderate
Changes
33
2 new · 1 exits
Top Sector
Pharmaceuticals & Biotechnology
71.2% of portfolio
📋 What Happened This Month HDFC Pharma and Healthcare Fund made 2 new additions and exited 1 stock this month. The biggest new buy was Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology) at 2.50% weight. Torrent Pharmaceuticals Limited was the biggest exit (Pharmaceuticals & Biotechnology), which was held at 2.13%. Among existing holdings, Sun Pharmaceutical Industries Limited saw the biggest increase — now at 9.20% of the portfolio. Glenmark Pharmaceuticals Limited was trimmed the most, now at 3.28%. Sun Pharmaceutical Industries Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 71.2%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Feb 2026 Apr 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 68.5% 70.1% +1.6%
Healthcare Services 29.1% 26.6% -2.5%
Healthcare Equipment & Supplies 0.6% 0.6% 0.0%
Apr 2026 May 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 70.1% 71.2% +1.1%
Healthcare Services 26.6% 26.9% +0.3%
Healthcare Equipment & Supplies 0.6% 0.6% +0.0%
🟢
Biggest New Buy
Zydus Lifesciences Limited
2.50% weight · Pharmaceuticals & Biotechnology
🔴
Biggest Exit
Torrent Pharmaceuticals Limited
2.13% was held · Pharmaceuticals & Biotechnology
Biggest Add
Sun Pharmaceutical Industries Limited
+1.15% · now 9.20%
Biggest Trim
Glenmark Pharmaceuticals Limited
-2.78% · now 3.28%
🤝 Other funds also bought this month
Zydus Lifesciences Limited 23 funds
Zydus Lifesciences Limited
LIC MF Healthcare Fund-Direct Plan-Growth
Bandhan Healthcare Fund - Direct Plan - Growth
Baroda BNP Paribas Health and Wellness Fund Direct Growth + more
Biocon Limited 18 funds
Biocon Limited
LIC MF Healthcare Fund-Direct Plan-Growth
Canara Robeco Mid Cap Fund- Direct Plan- Growth Option
SBI Retirement Benefit Fund - Aggressive Plan - Direct Plan - Growth + more
👋 Other funds also exited
Torrent Pharmaceuticals Limited 5 funds
Torrent Pharmaceuticals Limited
Motilal Oswal Active Momentum Fund- Direct-Growth
UNION RETIREMENT FUND
Union Consumption Fund - Direct Plan - Growth Option + more

What Changed in the Portfolio This Month?

Comparing Apr 2026 → May 2026

Apr 2026 May 2026
🟢 2 New Entries 🔴 1 Exit ↑ 15 Increased ↓ 15 Decreased
#StockSectorWeight (May 2026)
1
Zydus Lifesciences Limited
₹59.15 Cr
Pharmaceuticals & Biotechnology 2.50%
2
Biocon Limited
₹31.43 Cr
Pharmaceuticals & Biotechnology 1.33%
#StockSectorLast Weight (Apr 2026)
1
Torrent Pharmaceuticals Limited
₹45.97 Cr
Pharmaceuticals & Biotechnology 2.13%
#StockSectorApr 2026May 2026Change
1
Sun Pharmaceutical Industries Limited
₹217.44 Cr
Pharmaceuticals & Biotechnology 8.05% 9.20% +1.15%
2
Neuland Laboratories Limited
₹70.43 Cr
Pharmaceuticals & Biotechnology 1.97% 2.98% +1.01%
3
Global Health Limited
₹72.76 Cr
Healthcare Services 2.21% 3.08% +0.87%
4
Wockhardt Limited
₹57.55 Cr
Pharmaceuticals & Biotechnology 1.67% 2.44% +0.77%
5
Cipla Limited
₹116.29 Cr
Pharmaceuticals & Biotechnology 4.27% 4.92% +0.65%
6
Novartis India Limited
₹15.10 Cr
Pharmaceuticals & Biotechnology 0.10% 0.64% +0.54%
7
Acutaas Chemicals Ltd
₹106.19 Cr
Pharmaceuticals & Biotechnology 4.07% 4.50% +0.43%
8
Laurus Labs Limited
₹74.82 Cr
Pharmaceuticals & Biotechnology 2.80% 3.17% +0.37%
9
Shilpa Medicare Ltd
₹53.92 Cr
Pharmaceuticals & Biotechnology 2.04% 2.28% +0.24%
10
Thyrocare Technologies Limited
₹36.41 Cr
Healthcare Services 1.33% 1.54% +0.21%
#StockSectorApr 2026May 2026Change
1
Glenmark Pharmaceuticals Limited
₹77.55 Cr
Pharmaceuticals & Biotechnology 6.06% 3.28% -2.78%
2
IPCA Laboratories Limited
₹82.58 Cr
Pharmaceuticals & Biotechnology 4.39% 3.50% -0.89%
3
Max Healthcare Institute Limited
₹124.37 Cr
Healthcare Services 5.93% 5.26% -0.67%
4
Lupin Limited
₹128.87 Cr
Pharmaceuticals & Biotechnology 6.07% 5.45% -0.62%
5
Divi's Laboratories Limited
₹189.40 Cr
Pharmaceuticals & Biotechnology 8.56% 8.02% -0.54%
6
Anthem Biosciences Limited
₹98.16 Cr
Pharmaceuticals & Biotechnology 4.55% 4.15% -0.40%
7
Alkem Laboratories Limited
₹103.08 Cr
Pharmaceuticals & Biotechnology 4.69% 4.36% -0.33%
8
Fortis Healthcare Limited
₹80.49 Cr
Healthcare Services 3.71% 3.41% -0.30%
9
Aster DM Healthcare Limited
₹122.44 Cr
Healthcare Services 5.46% 5.18% -0.28%
10
Bajaj Healthcare Limited
₹17.19 Cr
Pharmaceuticals & Biotechnology 0.85% 0.73% -0.12%

What Stocks Does This Fund Hold?

32 stocks — May 2026

# Stock Sector Cap Weight & Value
1
₹217.44 Cr
Pharmaceuticals & Biotechnology
9.20%
2
₹189.40 Cr
Pharmaceuticals & Biotechnology
8.02%
3
₹128.87 Cr
Pharmaceuticals & Biotechnology
5.45%
4
₹124.37 Cr
Healthcare Services
5.26%
5
₹122.44 Cr
Healthcare Services
5.18%
6
₹116.29 Cr
Pharmaceuticals & Biotechnology
4.92%
7
₹106.19 Cr
Pharmaceuticals & Biotechnology
4.50%
8
₹103.08 Cr
Pharmaceuticals & Biotechnology
4.36%
9
₹98.16 Cr
Pharmaceuticals & Biotechnology
4.15%
10
₹82.58 Cr
Pharmaceuticals & Biotechnology
3.50%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 HDFC Mutual Fund — Portfolio & Holdings
See all funds managed by HDFC Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.